Utilizing literature research and enrichment analysis, we focused on the p53 signaling pathway, which exhibited the most significant difference among the key targets of Sappan lignum for PCa treatment, with the associated proteins BCL-2 and CCNB1. The gene discussed is BCL2; the disease is posterior cortical atrophy.